Post by BeOne Medicines
253,631 followers
At #EHA2026, we're sharing updates on our BTK degrader, currently the most advanced in clinical development. Hear from our Chief Medical Officer Amit Agarwal, M.D., Ph.D., on what this new data in relapsed/refractory CLL means for patients who need different treatment options. Learn more about BeOne at EHA: https://lnkd.in/gqumyPDr #FromFloorToFeed #TeamBeOne
Video Content